ACRO BIOMEDICAL CO., LTD. Research and Development Expense
ACRO BIOMEDICAL CO., LTD. (ACBM) reported Research and Development Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-07-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-07-24
- ACRO BIOMEDICAL CO., LTD. research and development expense for the quarter ending 2024-12-31 was $0.00.
- ACRO BIOMEDICAL CO., LTD. research and development expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. research and development expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. research and development expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- ACRO BIOMEDICAL CO., LTD. research and development expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ACRO BIOMEDICAL CO., LTD. research and development expense for fiscal 2023 was $4.79M, a 52.43% decline from fiscal 2022.
- ACRO BIOMEDICAL CO., LTD. research and development expense for fiscal 2022 was $10.08M, a 90.72% increase from fiscal 2021.
- ACRO BIOMEDICAL CO., LTD. research and development expense for fiscal 2021 was $5.29M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $0.00 derived: sum of 2 quarters · filed 2025-07-24 | $0.00 derived: sum of 3 quarters · filed 2025-07-24 | $0.00 10-K · filed 2025-07-24 |
| 2024-09-30 | $0.00 10-Q · filed 2025-07-23 | $0.00 derived: sum of 2 quarters · filed 2025-07-23 | $0.00 10-Q · filed 2025-07-23 | $0.00 derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-23 | $0.00 10-Q · filed 2025-07-23 | $0.00 derived: sum of 3 quarters · filed 2025-07-24 | $396.55K derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-03-31 | $0.00 10-Q · filed 2025-07-22 | $0.00 derived: sum of 2 quarters · filed 2025-07-24 | $396.55K derived: sum of 3 quarters · filed 2025-07-24 | $2.27M derived: sum of 4 quarters · filed 2025-07-24 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $396.55K derived: sum of 2 quarters · filed 2025-07-24 | $2.27M derived: sum of 3 quarters · filed 2025-07-24 | $4.79M 10-K · filed 2025-07-24 |
| 2023-09-30 | $396.55K 10-Q · filed 2025-07-23 | $2.27M derived: sum of 2 quarters · filed 2025-07-23 | $4.79M 10-Q · filed 2025-07-23 | $7.31M derived: sum of 4 quarters · filed 2025-07-23 |
| 2023-06-30 | $1.88M 10-Q · filed 2025-07-23 | $4.40M 10-Q · filed 2025-07-23 | $6.92M derived: sum of 3 quarters · filed 2025-07-23 | $9.44M derived: sum of 4 quarters · filed 2025-07-23 |
| 2023-03-31 | $2.52M 10-Q · filed 2025-07-22 | $5.04M derived: sum of 2 quarters · filed 2025-07-22 | $7.56M derived: sum of 3 quarters · filed 2025-07-22 | $10.08M derived: sum of 4 quarters · filed 2025-07-22 |
| 2022-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $5.04M derived: sum of 2 quarters · filed 2025-07-18 | $7.56M derived: sum of 3 quarters · filed 2025-07-18 | $10.08M 10-K · filed 2025-07-18 |
| 2022-09-30 | $2.52M 10-Q · filed 2025-07-11 | $5.04M derived: sum of 2 quarters · filed 2025-07-11 | $7.56M 10-Q · filed 2025-07-11 | $10.08M derived: sum of 4 quarters · filed 2025-07-11 |
| 2022-06-30 | $2.52M 10-Q · filed 2023-08-14 | $5.04M 10-Q · filed 2023-08-14 | $7.56M derived: sum of 3 quarters · filed 2023-08-14 | $9.68M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.52M 10-Q · filed 2023-08-02 | $5.04M derived: sum of 2 quarters · filed 2023-08-02 | $7.16M derived: sum of 3 quarters · filed 2023-08-02 | $7.81M derived: sum of 4 quarters · filed 2023-08-02 |
| 2021-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-21 | $4.64M derived: sum of 2 quarters · filed 2023-07-21 | $5.29M derived: sum of 3 quarters · filed 2023-07-21 | $5.29M 10-K · filed 2023-07-21 |
| 2021-09-30 | $2.12M 10-Q · filed 2022-11-21 | $2.77M derived: sum of 2 quarters · filed 2022-11-21 | $2.77M 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $641.73K 10-Q · filed 2022-08-12 | $641.73K 10-Q · filed 2022-08-12 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-22 | $0.00 derived: sum of 2 quarters · filed 2021-11-22 | $0.00 10-Q · filed 2021-11-22 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-23 | $0.00 10-Q · filed 2021-08-23 |